ArticlePathogens (Basel, Switzerland)2025

CD4/CD8 Ratio Increase in Female Living with HIV Switching to Cabotegravir-Rilpivirine: A Real-Life 24 Weeks Evaluation.

Serena Spampinato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.